Clinical trials: HAIC
Locally Advanced Hepatocellular Carcinoma
Natural Killer (NK) Cell Therapy in Locally Advanced HCC
This Phase 2a trial will evaluate the safety and efficacy of NK cell therapy combined with the hepatic artery infusion chemotherapy (HAIC) in patients with intermediate and/or locally advanced hepatocellular carcinoma (HCC).
- Trial name
- NCT05040438
- Testing
- Vax-NK/HCC
- Where
- South Korea
- Volunteers
- 17 people
- Sponsor
- Vaxcell Bio, Co., Ltd.